Document is current
Any future updates will be listed below
-
Authors
JelĂnková, Lucie
Jhun, Hugo
Eaton, Allison
Petrovsky, Nikolai http://orcid.org/0000-0002-1580-5245
Zavala, Fidel http://orcid.org/0000-0002-1414-6196
Chackerian, Bryce
-
Funding
Funding for this research was provided by:
Jeffrey Michael Gorvetzian Endowed Professorship for Biomedical Research Excellence
Bloomberg Family Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01-AI061142)
- License Information
-
More Information
Article History
Received: 7 August 2020
Accepted: 11 December 2020
First Online: 21 January 2021
Competing interests
: B.C. has equity stakes in Agilvax, Inc. and FL72, companies that do not have financial interest in malaria vaccines. N.P. is affiliated with Vaxine Pty Ltd, a company having a financial interest in Advax adjuvants. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
